In case of doubt medicines may also be listed as complementary on the basis of higher costs or less attractive cost-effectiveness in a variety of settings.
En caso de dúbida as medicinas poden tamén incluírse na lista comocomplementaria baseándose nos altos custos ou relación menos atractiva custo-efectividade en diversos escenarios.